Case Study Archives - Arazy Group Consultants Inc.

LICENSALE Mobile Now Available!

by arazygroup | Apr 14, 2022 | Blog, Case Study, Regulatory News Slider

Medtech Registration Just Became Mobile LICENSALE® Mobile is now available on the App Store and Google Play. Login with your portal registration credentials to view your registration projects from anywhere. MARKETING STATUS View your products’ real-time...

FDA Series- AMRA Medical

by arazygroup | Jun 14, 2019 | Blog, Case Study

AMRA is a ground-breaking, international digital health company at the forefront of medical imaging and precision medicine. The company has developed a new global standard in body composition assessment, delivering multiple fat and muscle biomarkers with unrivaled...

FDA Series- ETGAR Medical Instruments

by arazygroup | Apr 25, 2019 | Case Study

Late last year, the Dental Implants: Global Markets to 2023 report, was published detailing the industry’s expected high competition levels and a market to exceed US $6.5 Billion by 2024. With this industry quickly growing, Arazy Group Consultants is excited to work...

The rewards of expert regulatory navigation in Kazakhstan

by arazygroup | Sep 24, 2013 | Case Study

THE BACKGROUND The Republic of Kazakhstan is one of the world’s largest countries with a population of over 16 million people. The quickly growing economy in Kazakhstan has seen increased government spending in the health care sector since 2005, though regulations are...

Case study: finding the golden mean for class iii medical device registration with the USA FDA

by arazygroup | Apr 11, 2013 | Case Study

BACKGROUND On October 1st, 2012, the USA FDA introduced MDUFA III (Medical Device User Fee Amendments), which implemented new regulations for the registration on medical devices. While it is expected that the FDA will revise regulations at the beginning of the fiscal...

LICENSALE Mobile Now Available!

FDA Series- AMRA Medical

FDA Series- ETGAR Medical Instruments

The rewards of expert regulatory navigation in Kazakhstan

Case study: finding the golden mean for class iii medical device registration with the USA FDA

Search

Recent Posts

Recent Comments

Archives

Categories